Media Coverage (Selection)

March 2022

Boston Globe/Stat News, 24 March 2022

Despite competition, US cancer drug prices rose even as they fell in Germany and Switzerland

January 2022

SRF Echo der Zeit, January 30th, 2022

Firmen wollen Hürden für den EU-Export umgehen

 

SRF Tagesschau, January 26th 2022

Sicherheitslücke im Kundenportal des Schwarzfahrer-Registers

December 2021

Le Temps, December 11th, 2021

Les capsules destinées au suicide légales en Suisse? Pas si simple

 

NZZ, December 8th, 2021

Aktivisten sehen keine juristischen Hindernisse für einen Einsatz der Suizidkapsel in der Schweiz – doch es gibt grosse Zweifel am «Tesla der Sterbehilfe»

 

SRF, December 4th, 2021

Impfpflicht in der Schweiz? Fünf Fragen und Antworten

November 2021

SRF, November 19th, 2021

Expertin: «Genereller Impfzwang in der Schweiz nicht möglich»

September 2021

Business Insider, September 10th, 2021

One key study highlights how cancer-drug prices continue to rise in the US - even if they don't elsewhere

 

NZZ, September 2nd, 2021

Bei keiner anderen Krankheit wird so viel für Medikamente ausgegeben wie bei Krebs. Warum eigentlich?

August 2021

SRF, August 26th, 2021

Spaltet das Covid-Zertifikat die Gesellschaft? SRF 10 vor 10

July 2021

NZZ, July 28th, 2021

Masken nur noch für ungeimpfte Schüler? Die Politik hat die Bedeutung des Covid-Zertifikats unterschätzt und solche Aspekte nicht geregelt

July 2021

NZZ, July 3rd, 2021

Medikamente sind teuer - selbst wenn sie kaum wirken

July 2021

STAT News / Boston Globe, July 1st, 2021

U.S. cancer drug prices were higher at launch than in three European countries — and just kept climbing

April 2021

SRF 10 vor 10, April 22nd, 2021

Covid-Zertifikat: Staatsrechtlerin fordert breite Diskussion

 

NZZ, April 17th, 2021
Die Schweizer Pharmaforschung schwächelt bei der Digitalisierung

 

STAT News / Boston Globe, April 13th, 2021

Link: Europe tries to lower drug prices with small doses of transparency

PDF: Europe tries to lower drug prices with small doses of transparency (PDF, 290 KB)

 

WIRED, April 12th, 2021

This AI could help wipe-out colon cancer

February 2021 Swissinfo, February 19th, 2021
Secret discounts leave patients at drugmakers' mercy

 

Rundschau (SRF), February 17th, 2021
Medikamentenpreise werden immer häufiger zur Geheimsache

Blackbox Medi-Preis: Geheime Pharma-Verhandlungen

January 2021

NZZ, January 19th, 2021
Künstliche Intelligenz erkennt Covid-19 am Geräusch

October 2020

New York Times, October 29th, 2020

Gilead’s Covid-19 Drug is Mediocre. It Will Be a Blockbuster Anyway

September 2020

Nature Outlook, September 23rd, 2020

Research round-up: Precision oncology

Mai 2020

Swissinfo, Mai 1st, 2020

Swiss Study Sees No Link Between Cancer Drug Prices and Patient Benefits

January 2020

Los Angeles Times, January 3rd, 2020

Artificial intelligence has come to medicine. Are patients being put at risk?

December 2019

NZZ am Sonntag, December 29th, 2019

Tödliche Lotterie für Krebskranke: Patienten müssen immer länger auf neue Medikamente warten
 

Scientific American, December 24th, 2019

Artificial intelligence is rushing into patient care—and could raise risks

 

Plädoyer, December 2nd, 2019

Interessante Schnittstelle zwischen Recht und Medizin

November 2019

Rundschau (SRF), November 20th, 2019

Teure Krebsmedikamente

September 2019

European Society for Medical Oncology, September 29th, 2019

New Studies Question Whether Novel Anti-Cancer Drugs Are Worth Their Extra Cost

 

Weltwoche, September 4th, 2019

Kopf der Woche: Kerstin Vokinger

 

Higgs, September 4th, 2019

Die Anonymisierung in Gerichtsurteilen bringt nichts

 

Forbes, September 3rd, 2019

Researchers Use Big Data And AI To Remove Legal Confidentiality

 

Tagesschau (SRF), September 2nd, 2019

So können Anonymisierungen in Gerichtsurteilen aufgehoben werden

January 2019

Business Insider, January 14th, 2019

Medicare changes could have some patients paying more for drugs

 

Channel News Asia, January 14th, 2019

Medicare changes could have some patients paying more for drugs

December 2018

Plädoyer, December 3rd, 2018

In dubio pro Krankenkasse

October 2018

PracticeUpdate, October 22nd, 2018

ESMO 2018: Highest Benefit Cancer Drugs Receive Faster Approval in European Union

 

Cancerworld, October 21st, 2018

Reimbursement of newly approved cancer drugs may take more than one year

 

Science Daily, October 19th, 2018

Securing access to optimal cancer care through innovation, integration and sustainability

 

Health Economics, October 19th, 2018

Times Vary Widely on Reimbursement Decisions for New Cancer Drugs in EU

September 2018

Tagesanzeiger, September 29th, 2018

Gewinner sind fast immer die Krankenkassen